Canine
Canine Anisocoria: Neuro-Ophthalmic Localization and Workup
Bottom line
Localize canine anisocoria before naming a syndrome. Determine whether the asymmetry is greater in light or darkness, document vision and direct and consensual PLRs, and complete fluorescein staining, tonometry, anterior-segment and fundic examination before pharmacologic testing. Painful ocular disease and glaucoma outrank an elegant neurologic localization when they are clinically present.[1][2]
Establish acuity, exposure, and stability
Ask when the asymmetry was first seen, whether photographs document earlier symmetry, and whether onset followed trauma, ophthalmic or transdermal medication, grooming products, plant exposure, neck procedures, ear disease, or neurologic change. Obtain every topical product used on the patient and household contacts.
Triage marked ocular pain, corneal edema, buphthalmos, trauma, acute vision loss, altered mentation, or multifocal neurologic deficits. The paired owner guide emphasizes observable same-day and emergency indicators.
Decide which pupil is abnormal
Observe from straight ahead under controlled photopic and scotopic conditions before touching the eyes. If anisocoria increases in bright light, the larger pupil is failing to constrict normally. If it increases in darkness, the smaller pupil is failing to dilate.[1][4]
Document resting pupil diameter, symmetry of palpebral fissures and globes, third-eyelid position, strabismus, nystagmus, and ocular motility. Repeat after the patient acclimates; fear, asymmetric illumination, and head position can confound a subtle difference.
Map the afferent and efferent pathways
Assess visual behavior, menace response, dazzle response when useful, and direct and consensual PLRs in both directions. A dilated poorly responsive pupil with impaired vision raises retinal, optic-nerve, severe glaucoma, or other afferent disease, while a large pupil with retained vision shifts attention toward iris atrophy, drug effect, or parasympathetic efferent dysfunction.[1][3]
For the miotic pupil, compare dilation in darkness and look for ptosis, enophthalmos, and third-eyelid elevation. Horner syndrome remains a pathway localization rather than an etiology. Corneal pain and uveitis can create miosis and some overlapping adnexal findings, so exclude primary ocular disease first.[4]
Complete the ocular minimum database
Perform fluorescein staining before topical manipulation, measure intraocular pressure, inspect the iris and anterior chamber with magnification and focal illumination, and examine the lens, vitreous, retina, and optic disc through clear media. Tear testing is added according to the ocular-surface presentation and before disruptive drops.
Glaucoma is defined by pressure-related retinal and optic-nerve injury; tonometry and ophthalmoscopy are central to diagnosis.[2] Anterior uveitis may produce miosis, aqueous flare, low pressure, pain, and secondary complications. Iris atrophy may be visible as scalloping or stromal thinning and is often more convincing when other ocular and neurologic tests are normal.
The acute vision-loss workup covers the broader blind patient. Facial asymmetry or blink dysfunction should be integrated with the canine facial-paralysis localization.
Use pharmacologic testing selectively
Pharmacologic testing can support parasympathetic or sympathetic dysfunction, but concentration, timing, corneal integrity, prior medications, chronicity, and denervation hypersensitivity affect interpretation. Record baseline photographs and objective pupil measurements, test both eyes when appropriate, and avoid treating a response as a complete etiologic diagnosis.[3][4]
Do not perform localization drops before ruling out urgent ocular disease or if the result will not change the next diagnostic decision. Consultation with ophthalmology or neurology is preferable when protocols or interpretation are unfamiliar.
Extend diagnostics from the localization
A painful ocular lesion may be self-localizing. Suspected Horner syndrome directs examination along the hypothalamic-to-thoracic-to-cervical-to-middle-ear pathway, with otic examination and imaging selected by associated signs. Oculomotor dysfunction, abnormal eye position, additional cranial-nerve deficits, or altered mentation increases concern for brainstem or orbital disease.
Blood pressure, CBC, chemistry, infectious testing, ocular ultrasound, electroretinography, thoracic imaging, CT, or MRI are chosen from the lesion localization and systemic context. Avoid indiscriminate panels that do not address the mapped pathway.
Frequently Asked Questions
What is the first localization step in anisocoria?
Compare the pupils in bright and dim light. Greater anisocoria in light implicates failure of the larger pupil to constrict; greater anisocoria in darkness implicates failure of the smaller pupil to dilate.
Which tests should precede pharmacologic testing?
Document vision, direct and consensual PLRs, dazzle where relevant, fluorescein staining, tonometry, anterior-segment examination, and fundus findings before altering pupil behavior.
How does ocular pain affect pupil size?
Corneal pain and anterior uveitis commonly produce miosis through reflex and inflammatory pathways, while acute glaucoma commonly produces a larger, poorly responsive pupil.
When is Horner syndrome likely?
Suspect sympathetic denervation when the smaller pupil fails to dilate in darkness and accompanies ptosis, enophthalmos, or third-eyelid elevation, after excluding painful ocular causes.
Does a preserved menace response exclude optic disease?
No single response is sufficient. Integrate visual behavior, PLRs, dazzle, fundus examination, ocular media clarity, and neurologic localization.
When is advanced imaging appropriate?
Use imaging when examination localizes to the orbit, optic nerve, brainstem, cervical sympathetic pathway, middle ear, thorax, or when progressive or multifocal neurologic signs remain unexplained.
References
Voyage Dispatch · thevoyage.ai/forvets/knowledge/canine-anisocoria-neuro-ophthalmic-workup · published Sep 28, 2026 · verify dosing against the current formulary before prescribing
More clinical updates
Canine Acute Vision Loss: Localization and Diagnostic Workup
A localization-first approach to acute canine blindness, separating opaque media, retinal dysfunction, optic-nerve disease, and central visual pathway lesions.
Read →Canine Facial Paralysis: Neurologic Localization and Diagnostic Workup
A localization-first approach to canine CN VII dysfunction, separating peripheral facial neuropathy, middle-ear disease, brainstem lesions, and mimics while protecting the cornea.
Read →Canine SCCED (Indolent Corneal Ulcers): Debridement and Outcomes
A practical clinical hub on spontaneous chronic corneal epithelial defects in dogs: how to diagnose an indolent ulcer, the mechanical debridement ladder from cotton-tip to diamond burr to grid keratotomy to superficial keratectomy, comparative single-procedure healing rates, bandage lens and serum adjuncts, and when to escalate.
Read →Canine Keratoconjunctivitis Sicca (KCS): Diagnosis and Treatment
A practical clinical hub on canine keratoconjunctivitis sicca: Schirmer tear test diagnosis and severity thresholds, topical calcineurin inhibitors (ciclosporin, tacrolimus) as first-line, tear replacement, oral pilocarpine for neurogenic KCS, parotid duct transposition for refractory cases, and where injectable PRP plus oral omega-3 fit as adjuncts.
Read →